News tagged with adenocarcinoma
Mutated Kras spins a molecular loop that launches pancreatic cancer
Scientists have connected two signature characteristics of pancreatic cancer, identifying a self-perpetuating "vicious cycle" of molecular activity and a new potential target for drugs to treat one of the most lehal forms ...
Jan 26, 2012 |
5 / 5 (1) |
0
Genetic composition of multicentric lung tumors appears to be similar
Multicentric carcinogenesis with the same genetic mutation appears to occur in lung adenocarcinoma, according to data presented at the AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and ...
Jan 09, 2012 |
not rated yet |
0
Gene fusion in lung cancer afflicting never-smokers may be target for therapy
Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked. In a study published online today in Genome Research, researchers have identified a previously unknown gene f ...
Dec 22, 2011 |
not rated yet |
0
|
Goats could increase the risk of a rare lung cancer
Exposure to goats could increase the risk of a certain type of lung cancer, according to French researchers.
Sep 25, 2011 |
not rated yet |
1
EGFR essential for the development of pancreatic cancer
The epidermal growth factor receptor (EGFR) gene is essential for KRAS-driven pancreatic cancer development, according to study results presented at the Second AACR International Conference on Frontiers in Basic Cancer Research, ...
Sep 15, 2011 |
5 / 5 (1) |
0
Researchers discover blood proteins associated with early development of lung cancer
A research team led by Fred Hutchinson Cancer Research Center has discovered proteins in the blood that are associated with early lung cancer development in mice and humans. The advance brings the reality of a blood test ...
Sep 12, 2011 |
5 / 5 (2) |
0
|
Lung cancer ALK rearrangement may predict pemetrexed efficacy, study shows
Patients with ALK-rearranged non-small cell lung cancer (NSCLC) responded significantly better to pemetrexed (brand name: Alimta) than patients whose cancer did not show ALK translocation, according to research published ...
Sep 01, 2011 |
not rated yet |
0
Lung tumors in never-smokers show greater genomic instability than those in smokers
Lung adenocarcinomas in people who have never smoked show greater genome instability than those in smokers, supporting the theory that lung cancer in never smokers arises through different pathways, according to research ...
Jul 05, 2011 |
5 / 5 (1) |
0
ALK rearrangement found in nearly 10 percent of patients in Lung Cancer Mutation Consortium
ALK rearrangement has been found in 9.6% of lung cancer patients tested in the Lung Cancer Mutation Consortium, and MET amplification in another 4.1%, reflecting how many patients might benefit from targeted therapies such ...
Jul 05, 2011 |
not rated yet |
0
Sequence of ovarian genome identifies predominant gene mutations, points to possible treatment
The genome of the most common form of ovarian cancer is characterized by a few common gene mutations but also surprisingly frequent structural changes in the genome itself, said members of The Cancer Genome Atlas, including ...
Jun 29, 2011 |
not rated yet |
0
|
Barrett's esophagus carries lower risk of malignancy than previously reported
Patients with Barrett's esophagus may have a lower risk of esophageal cancer than previously reported, according to a large, long-term study published online June 16 in the Journal of the National Cancer Institute.
Jun 16, 2011 |
not rated yet |
0
|
Researchers home in on genetic signature of esophageal cancer
University of Rochester Medical Center researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.
May 18, 2011 |
not rated yet |
0
|
Team pinpoints role of key protein in pancreatic ductal adenocarcinoma
A team based at North Carolina Central University (NCCU) and UNC Lineberger Comprehensive Cancer Center has established a connection between a known cancer gene called KRAS and a protein called Pim-1 kinase.
May 11, 2011 |
not rated yet |
0
|
Long-term follow-up shows multipolar electrocoagulation ablation effective for Barrett's esophagus
A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term. No adenocarcinoma (cancer) or high-grade ...
Apr 25, 2011 |
not rated yet |
0
More tests needed for oesophageal cancer patients
A University of Adelaide medical researcher says current treatment for people diagnosed with oesophageal cancer could be improved with additional pathology tests.
Mar 01, 2011 |
5 / 5 (1) |
0
Adenocarcinoma
Adenocarcinoma is a cancer originating in glandular tissue. This tissue is also part of a larger tissue category known as epithelial. Epithelial tissue includes skin, glands and a variety of other tissue that lines the cavities and organs of the body. Epithelium is derived embryologically from ectoderm, endoderm and mesoderm. To be classified as adenocarcinoma, the cells do not necessarily need to be part of a gland, as long as they have secretory properties. This form of carcinoma can occur in some higher mammals, including humans. Well differentiated adenocarcinomas tend to resemble the glandular tissue that they are derived from, while poorly differentiated may not. By staining the cells from a biopsy, a pathologist will determine whether the tumor is an adenocarcinoma or some other type of cancer. Adenocarcinomas can arise in many tissues of the body due to the ubiquitous nature of glands within the body. While each gland may not be secreting the same substance, as long as there is an exocrine function to the cell, it is considered glandular and its malignant form is therefore named adenocarcinoma. Endocrine gland tumors, such as a VIPoma, an insulinoma, a pheochromocytoma, etc, are typically not referred to as adenocarcinomas, but rather, are often called neuroendocrine tumors. If the glandular tissue is abnormal, but benign, it is said to be an adenoma. Benign adenomas typically do not invade other tissue and rarely metastasize. Malignant adenocarcinomas invade other tissues and often metastasize given enough time to do so.
For more information about Adenocarcinoma, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.